BTAI
6:00 AM
BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
BioXcel Therapeutics intends to complete a court-supervised sale transaction, in an effort to maximize value for all stakeholders Teva Pharmaceuticals to serve as “stalking horse” bidder in a court-supervised 363 auction process BioXcel Therapeutics has secured a commitment for debtor-in-possession
bioxceltherapeutics.com